Company: RGNX
Filing Date: 2025-05-19
Form Type: 8-K
Source: 0001193125-25-122456
Chunk: 1

Company: REGENXBIO Inc.
Filing Date: 2025-05-19
Form: 8-K
Item: Item 2.03
Chunk 1
---
 license agreement for Zolgensma®, such royalty payments shall only be included after repayment of the cap amount under the existing royalty purchase agreement between the Company and HCRx dated as of December 22, 2020. As of the Closing Date, the license agreements giving rise to the Royalty Interest and certain other related assets and obligations of the Company were contributed to REGENXBIO RS. The proceeds of the Royalty Bond will be used by REGENXBIO RS to purchase the assets related to the Royalty Interest contributed by the Company to REGENXBIO RS.